Back to DnB Asset Management AS DnB Asset Management AS

ALXNALXN
12 quarters

Position history for DnB Asset Management ASDnB Asset Management AS's holdings in ALEXION PHARMACEUTICALS INC

DnB Asset Management AS previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC), worth $0 as of 2021-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$2.5M

Total Shares Change

-25,896

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2021-Q2
Decreased
32,063
-96.8%
$5.9M0.0%
0
2021-Q1
Increased
988,883
+243.8%
$151.2M1.1%
77
2020-Q4
Increased
287,622
+186.3%
$44.9M0.4%
56
2020-Q3
Decreased
100,464
-86.6%
$11.5M0.1%
0
2020-Q2
Decreased
748,336
-3.5%
$84M1.0%
0
2020-Q1
Increased
775,906
+2045.8%
$69.7M1.0%
75
2019-Q4
Decreased
36,159
-23.9%
$3.9M0.0%
0
2019-Q3
Increased
47,485
+4.9%
$4.7M0.1%
28
2019-Q2
Increased
45,269
+33.5%
$5.9M0.1%
35
2019-Q1
Increased
33,907
+30.9%
$4.6M0.1%
34
2018-Q4
New
25,896
-
$2.5M0.0%
36

Other major holders of ALXN: FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, HBK INVESTMENTS L P

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used